206 related articles for article (PubMed ID: 18041669)
21. Lipid-based biomarkers for cancer.
Fernandis AZ; Wenk MR
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2830-5. PubMed ID: 19570730
[TBL] [Abstract][Full Text] [Related]
22. Application of lipidomics and metabolomics to the study of adipose tissue.
Mattila I; Seppänen-Laakso T; Suortti T; Oresic M
Methods Mol Biol; 2008; 456():123-30. PubMed ID: 18516557
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics and computational methods for lipidomics.
Niemelä PS; Castillo S; Sysi-Aho M; Oresic M
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2855-62. PubMed ID: 19200789
[TBL] [Abstract][Full Text] [Related]
24. Novel biomarkers of acute kidney toxicity.
Goodsaid FM; Blank M; Dieterle F; Harlow P; Hausner E; Sistare F; Thompson A; Vonderscher J
Clin Pharmacol Ther; 2009 Nov; 86(5):490-6. PubMed ID: 19710639
[TBL] [Abstract][Full Text] [Related]
25. Lipidomics applications for disease biomarker discovery in mammal models.
Zhao YY; Cheng XL; Lin RC; Wei F
Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
[TBL] [Abstract][Full Text] [Related]
26. The European lipidomics initiative: enabling technologies.
van Meer G; Leeflang BR; Liebisch G; Schmitz G; Goñi FM
Methods Enzymol; 2007; 432():213-32. PubMed ID: 17954219
[TBL] [Abstract][Full Text] [Related]
27. Mass spectrometry: from proteomics to metabolomics and lipidomics.
Griffiths WJ; Wang Y
Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
[TBL] [Abstract][Full Text] [Related]
28. [The presence and characteristics of interrelations between lipid metabolism disorder and systemic inflammation].
Ambroskina VV; Kriachok TA; Larionov OP; Bratus' VV; Talaieva TV
Fiziol Zh (1994); 2008; 54(3):36-46. PubMed ID: 18763578
[TBL] [Abstract][Full Text] [Related]
29. Lipidomics: new tools and applications.
Wenk MR
Cell; 2010 Dec; 143(6):888-95. PubMed ID: 21145456
[TBL] [Abstract][Full Text] [Related]
30. Computational biology for cardiovascular biomarker discovery.
Azuaje F; Devaux Y; Wagner D
Brief Bioinform; 2009 Jul; 10(4):367-77. PubMed ID: 19276200
[TBL] [Abstract][Full Text] [Related]
31. [Molecular mechanisms of lipid metabolism in metabolic syndrome].
Hirata K
Nihon Rinsho; 2007 Jul; 65 Suppl 7():79-83. PubMed ID: 17824016
[No Abstract] [Full Text] [Related]
32. Comprehensive lipid analysis: a powerful metanomic tool for predictive and diagnostic medicine.
Watkins SM
Isr Med Assoc J; 2000 Sep; 2(9):722-4. PubMed ID: 11062783
[TBL] [Abstract][Full Text] [Related]
33. Lipidomics applications in health, disease and nutrition research.
Murphy SA; Nicolaou A
Mol Nutr Food Res; 2013 Aug; 57(8):1336-46. PubMed ID: 23729171
[TBL] [Abstract][Full Text] [Related]
34. Neurolipidomics: challenges and developments.
Han X
Front Biosci; 2007 Jan; 12():2601-15. PubMed ID: 17127266
[TBL] [Abstract][Full Text] [Related]
35. A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development.
Zhao L; Jin W; Rader D; Packard C; Feuerstein G
Biochem Pharmacol; 2009 Aug; 78(4):315-25. PubMed ID: 19539799
[TBL] [Abstract][Full Text] [Related]
36. Lipidomics-based safety biomarkers for lipid-lowering treatments.
Laaksonen R; Jänis MT; Oresic M
Angiology; 2008; 59(2 Suppl):65S-8S. PubMed ID: 18632766
[TBL] [Abstract][Full Text] [Related]
37. Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome.
Aguilera CM; Gil-Campos M; Cañete R; Gil A
Clin Sci (Lond); 2008 Feb; 114(3):183-93. PubMed ID: 18184112
[TBL] [Abstract][Full Text] [Related]
38. The emerging role of plasma lipidomics in cardiovascular drug discovery.
Puri R; Duong M; Uno K; Kataoka Y; Nicholls SJ
Expert Opin Drug Discov; 2012 Jan; 7(1):63-72. PubMed ID: 22468894
[TBL] [Abstract][Full Text] [Related]
39. Lipid metabolism: reviews of HDL and cholesterol efflux, ethanol and hepatic lipid metabolism and lipid disorders during childhood.
van Heyningen C
Curr Opin Lipidol; 2009 Feb; 20(1):77-8. PubMed ID: 19106711
[No Abstract] [Full Text] [Related]
40. How to study lipidomes.
Seppänen-Laakso T; Oresic M
J Mol Endocrinol; 2009 Mar; 42(3):185-90. PubMed ID: 19060177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
